Tag Archives: ALL

Top 10 Medical Stocks To Own Right Now

In an agewhen vending machines can dispense anything from lipstick to headphones, perhaps it was only a matter of time before the industry would dream up a new, automated way to help people stock up on marijuana.

American Green, a Phoenix-based medical-cannabis technology company, has unveiled a prototype for a vending machine that uses biometric verification technology to sell controlled and age-restricted items. Besides dope, it can dispense other items where positive identification is a purchasing prerequisite — pharmaceuticals, casino chips, alcoholic beverages or evenguns.

The device would be ideal for casinos that want to go cashless, drug stores looking to sell prescription-only or other controlled items like antihistiminesand pot dispensaries that have customers who would rather avoid a face-to-face transaction, according to American Green’s Chief Operating Officer Stephen Shearin.

Top 10 Medical Stocks To Own Right Now: Allstate Corporation (ALL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Principal Financial Group Inc. cut its position in Allstate (NYSE:ALL) by 7.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 2,075,644 shares of the insurance provider’s stock after selling 165,995 shares during the quarter. Principal Financial Group Inc.’s holdings in Allstate were worth $196,771,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Allion (CURRENCY:ALL) traded up 4.4% against the US dollar during the 24 hour period ending at 8:00 AM Eastern on May 29th. One Allion coin can currently be purchased for $0.0143 or 0.00000193 BTC on popular exchanges including YoBit, Cryptopia and CoinExchange. Allion has a total market cap of $88,618.00 and $1,993.00 worth of Allion was traded on exchanges in the last 24 hours. During the last week, Allion has traded down 4.3% against the US dollar.

  • [By Lee Jackson]

    Insurance companies tend to do well as rates rise, and this sector giant may be an outstanding pick for investors. Allstate Corp. (NYSE: ALL) is the largest publicly traded personal lines insurance company, with about 12% of the personal lines market (one in eight households). Allstate is primarily a direct writer. Besides a full array of personal lines P/C products (preferred, standard and nonstandard auto insurance, and homeowners’ insurance), the company also offers life insurance and annuity products.

  • [By Stephan Byrd]

    Guggenheim Capital LLC grew its position in shares of Allstate Corp (NYSE:ALL) by 4.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 530,877 shares of the insurance provider’s stock after purchasing an additional 22,475 shares during the period. Guggenheim Capital LLC’s holdings in Allstate were worth $50,327,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own Right Now: OCI Partners LP(OCIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    OCI Partners (NYSE:OCIP) shares hit a new 52-week high and low on Monday . The company traded as low as $10.45 and last traded at $10.45, with a volume of 1357 shares changing hands. The stock had previously closed at $10.40.

  • [By Joseph Griffin]

    Ingevity (NYSE: NGVT) and OCI Partners (NYSE:OCIP) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk.

  • [By Shane Hupp]

    Shares of OCI Partners (NYSE:OCIP) hit a new 52-week high and low during mid-day trading on Wednesday . The stock traded as low as $10.00 and last traded at $9.85, with a volume of 0 shares traded.

Top 10 Medical Stocks To Own Right Now: Smith(wh)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wyndham Hotels & Resorts (NYSE: WH) and Las Vegas Sands (NYSE:LVS) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

  • [By Stephan Byrd]

    Wyndham Hotels & Resorts (NYSE:WH) declared a dividend on Monday, May 21st, Fidelity reports. Stockholders of record on Friday, June 15th will be given a dividend of 0.25 per share on Friday, June 29th. The ex-dividend date is Thursday, June 14th.

Top 10 Medical Stocks To Own Right Now: BWX Technologies, Inc.(BWXT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Synovus Financial Corp acquired a new stake in shares of BWX Technologies (NYSE:BWXT) during the first quarter, Holdings Channel reports. The fund acquired 1,892 shares of the technology company’s stock, valued at approximately $122,000.

  • [By Ethan Ryder]

    News coverage about BWX Technologies (NYSE:BWXT) has trended somewhat positive on Friday, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BWX Technologies earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 44.8987761555585 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now: Tetra Technologies, Inc.(TTI)

Advisors’ Opinion:

  • [By Lee Jackson]

    This small-cap oilfield services play has some big upside potential. Tetra Technologies Inc. (NYSE: TTI) is a diversified oil and gas services company, with the bulk of its revenue derived from drilling and completion fluids, as well as contract compression services by way of its 42% stake in CSI Compressco.

  • [By Stephan Byrd]

    Tetra Technologies (NYSE: TTI) and Chaparral Energy (OTCMKTS:CHPE) are both small-cap oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Own Right Now: New York Times Company (NYT)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    The only U.S. papers which have been able to buck these trends are The New York Times (NYSE: NYT), the Jeff Bezos-owned Washington Post, and The Wall Street Journal, each of which produces content that appeals to enough people that they have created large digital subscription bases. At the end of the last reported quarter, The New York Times had over 2.6 million digital-only subscriptions. No other newspaper has a number which is even close.

  • [By Asit Sharma]

    For several quarters, The New York Times'(NYSE:NYT)earnings conference calls have centered on opportunities arising from the company’s booming digital customer growth. No longer do executives face innumerable questions from analysts on weak print customer volume, or declining print advertising spends. Now, discussions revolve around the journalism and media giant’s strategies to maintain its online services momentum.

  • [By Natalie Walters]

    The New York Times (NYSE:NYT)made a point of alerting investors in its latest earnings call that it would be shifting its attention to some big TV and film projects this year.

  • [By Daniel Sparks]

    The New York Times Company(NYSE:NYT) stock has seen quite the run recently, rising 35% year to date and 41% in the past 12 months. The stock’s gain comes as the company has proved its recent reinvigorated growth could be sustained beyond the big bumpit saw from the 2016 election.

  • [By Natalie Walters]

    The New York Times Co. (NYSE:NYT) has been under additional scrutiny since the 2016 election as President Donald Trump continues to call out the flagship publication for what he deems “fake news.” But the company is holding up under the spotlight, reporting quarterly revenue of $413.9 million, up from $398 million in the year-ago quarter.

  • [By Douglas A. McIntyre]

    In just a few weeks, the largest publicly traded newspaper companies will post their first-quarter results. Other than New York Times Co. (NYSE: NYT), which has had success selling digital subscriptions, last year’s typical results were revenue drops of 5% to 10%.

Top 10 Medical Stocks To Own Right Now: Capital Southwest Corporation(CSWC)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Capital Southwest (NASDAQ:CSWC) Q4 2018 Earnings Conference CallJun. 5, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Capital Southwest Co. (NASDAQ:CSWC) announced a quarterly dividend on Tuesday, June 5th, Wall Street Journal reports. Investors of record on Tuesday, June 26th will be paid a dividend of 0.29 per share by the asset manager on Monday, July 2nd. This represents a $1.16 annualized dividend and a dividend yield of 6.80%. The ex-dividend date of this dividend is Monday, June 25th. This is a boost from Capital Southwest’s previous quarterly dividend of $0.28.

  • [By Max Byerly]

    Capital Southwest (NASDAQ: CSWC) and TRIPLEPOINT VEN/COM (NYSE:TPVG) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By ]

    AK Steel Holding (AKS) : “They’re not the lo- cost producer. That’s Nucor (NUE) and that’s the way you want to go.”

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nucor (NUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    United States Steel (X) : “We’ve got Nucor (NUE) and that’s the one you want to buy.”

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

  • [By Jon C. Ogg]

    Nucor Corp. (NYSE: NUE) was last seen trading up 1.8% at $62.67, but this was a $68 stock as recently as June 18. It is a top steel player and was supposed to be one of the would-be Trump steel tariff winners. Its 52-week range is $51.67 to $70.48, and the consensus target price is $77.70.

Top 10 Medical Stocks To Own Right Now: Pure Cycle Corporation(PCYO)

Advisors’ Opinion:

  • [By Max Byerly]

    Artesian Resources Co. Class A (NASDAQ: ARTNA) and Pure Cycle (NASDAQ:PCYO) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.

Top 10 Medical Stocks To Own Right Now: Tidewater Inc.(TDW)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Tidewater (NYSE:TDW) Q1 2018 Earnings Conference CallMay. 15, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    News headlines about Tidewater (NYSE:TDW) have been trending somewhat positive on Monday, Accern reports. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tidewater earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9223416083374 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Best Biotech Stocks For 2019

Investment company Wechter Feldman Wealth Management, Inc. buys SPDR Select Sector Fund – Utilities, Vanguard Total Stock Market, SPDR Series Trust S&P Biotech, Berkshire Hathaway Inc, Vanguard Total Bond Market, sells iShares Core S&P Mid-Cap, iShares Russell Mid-cap Value, Vanguard High Dividend Yield ETF – DNQ, iShares Russell 1000 Value, Vanguard Mid-Cap ETF – DNQ during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Wechter Feldman Wealth Management, Inc.. As of 2017-06-30, Wechter Feldman Wealth Management, Inc. owns 27 stocks with a total value of $124 million. These are the details of the buys and sells.

New Purchases: XLU, XBI, BRK.B, Added Positions: VTI, IWV, TIP, AGG, IWB, OEF, IVV, VIG, BND, JNJ, Reduced Positions: T, XOM, GE, Sold Out: IJH, IWS, VYM, IWD, VO, VTV, VB, IJR,

For the details of Wechter Feldman Wealth Management, Inc.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Wechter+Feldman+Wealth+Management%2C+Inc.

Best Biotech Stocks For 2019: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By David Kretzmann]

    Since its IPO in March 2014, 2U (NASDAQ:TWOU) stock is up over 160% as the company forges partnerships with famous schools, including Georgetown, Yale, Berkeley, and New York University.

Best Biotech Stocks For 2019: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

Best Biotech Stocks For 2019: Allstate Corporation (The)(ALL)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

Best Casino Stocks To Buy Right Now

Family and friends lend out about $89 billion in cash each year. More than a third of that total is used to help finance a new business while 6% of first-time home buyers get help from (usually) their parents. About a quarter of those loans were never paid back at all and more than 40% were only paid back partially.

The moral here is not to lend more than you can afford to lose. Sort of like playing poker or blackjack in a casino.

But what about lending your credit card to someone else, either a family member or good friend? How likely is that result in a bad outcome? According to a new survey of 2,253 U.S. adults by researchers at CreditCards.com, more than one-third of the time.

Nearly half (49%) of respondents who have ever owned a credit card admitted that they had lent the card to spouses, children, friends, co-workers or “other people” to make a purchase. More than a third (35%) experienced negative consequences.

Overspending by the card’s borrower hit 19% of the trusting souls, while 14% never got repaid and 10% reported that the card was lost, stolen or never returned. By extrapolation, the researchers estimate that 36 million Americans have been hurt by lending a credit card to someone else.

Best Casino Stocks To Buy Right Now: Allstate Corporation (The)(ALL)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

Best Casino Stocks To Buy Right Now: CBRE Group, Inc.(CBG)

Advisors’ Opinion:

  • [By Lee Jackson]

    CBRE Group Inc. (NYSE: CBG) had a top hedge fund step in again last week and buy a huge block of shares. Value Act bought a total of 1,200,000 sharesat between $26.85 and $27.15. That cost the fund a gigantic $32 million.The companyoperates as a commercial real estate services and investment company worldwide, and its shares traded onFriday at $27.80.

  • [By WWW.GURUFOCUS.COM]

    For the details of HAHN CAPITAL MANAGEMENT LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=HAHN+CAPITAL+MANAGEMENT+LLC

    These are the top 5 holdings of HAHN CAPITAL MANAGEMENT LLCHexcel Corp (HXL) – 899,271 shares, 4.71% of the total portfolio. Shares reduced by 1.47%Mohawk Industries Inc (MHK) – 212,515 shares, 4.68% of the total portfolio. Shares reduced by 2.38%CBRE Group Inc (CBG) – 1,299,059 shares, 4.34% of the total portfolio. Shares reduced by 2.39%Becton, Dickinson and Co (BDX) – 241,184 shares, 4.25% of the total portfolio. Shares reduced by 2.37%Ross Stores Inc (ROST) – 642,103

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

Best Casino Stocks To Buy Right Now: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedbuying small cap performance improvement stock GSE Systems (NYSEMKT: GVP):

    GSE Systems is another somewhat-preemptive position; we think the recent support at the 100-day moving average line (gray) and subsequent string of higher lows is telling. There’s a ceiling at $3.27 that needs to be cleared, but we fear waiting on that to happen because once it does, GVP shares could be catapulted to a price we don’t want to chase.

Best Casino Stocks To Buy Right Now: OncoMed Pharmaceuticals, Inc.(OMED)

Advisors’ Opinion:

  • [By Paul Ausick]

    OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped about 5.3% Wednesday to post a new 52-week low of $4.69 after closing at $4.95 on Tuesday. The stock’s 52-week high is $15.49. Volume was more than double the daily average of around 270,000 shares. The company had no specific news Wednesday.

  • [By Teresa Rivas]

    OncoMed Pharmaceuticals (OMED) has lost more than a third of its value Monday, after Bayer decided not to exercise its option to license the firms Phase II-ready WNT pathway inhibitors Vantictumab and Ipafricept, which treat pancreatic cancer.

    Pixabay

    That wasnt the only bad news, however, as the firms randomized-controlled Phase II “YOSEMITE” trial of pancreatic cancer drug demcizumab also missed its primary endpoint.

    Leerinks Michael Schmidt and his team reiterated a Market Perform rating on the stock Monday, and lowered their price target from $10 to $6 on the news, calling it a “double setback” for OncoMed.

    More detail from the note:

    This is a major setback for OMED and in our view for the cancer stem cell targets more broadly, which have been a difficult area of drug development. We’ve been cautious on the probability-of-success of these agents and see more promise on OMED’s recent efforts in building a second area of focus in immuno-oncology. Going forward, OMED plans to review and prioritize its R&D pipeline after results from the still pending tarextumab Phase II “PINNACLE” trial in small cell lung cancer (SCLC) and data from the demcizumab “DENALI” trial in NSCLC are available in 2Q17. We remain MP rated in light of the uncertainties around OMED’s pipeline and strategy at this point. We previously assigned a 30% probability of success (POS) to demcizumab which we now have removed from our model. We also hink chances that CELG will opt-into this program are slim and we have removed associated POS-adjusted milestone payments from our model. OMED has cash to run operations through 3Q18.

    OncoMed is down 36.1% to $5.60 this afternoon.

  • [By Paul Ausick]

    OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped nearly 44% Monday to post a new 52-week low of $4.94 after closing Friday at $8.76. The stock’s 52-week high is $15.49. Volume of about 3.3 million shares was nearly 20 times the daily average of around 182,000. A proposed deal with Bayer AG fell through and one of the company’s drugs failed a phase 2 clinical trial.

Best Casino Stocks To Buy Right Now: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) got a boost, shooting up 10 percent to $9.71. Nabriva Therapeutics announced a $80 million common stock offering.

  • [By Lisa Levin]

    Nabriva Therapeutics plc (NASDAQ: NBRV) shares shot up 37 percent to $9.38 after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.

Hot Warren Buffett Stocks To Watch For 2018

Buffett sold a large portion of his stake in Munich Re (HAM:MUV2) in 2015 citing a terrible outlook for the reinsurance business. A year and a half later, it’s clear he would have made continued to profit on the stock if he had held it, but it is unclear how long that will last and whether his vision is still to come true.

The CEO of Berkshire Hathaway (BRK.A)(BRK.B) held more than 10% of Munich Re, one of the world’s largest reinsurers with 50 billion euros in revenue, since 2010 and at one point held around 12% of the company. Munich Re’s stock in October 2010 started around $103.65 per share, but Buffett’s annual letter from that year showed that he paid roughly $150 per share for the entire 19,259,600-share holding with a total cost of $2.896 billion.

NEW YORK, NY – JANUARY 27: Bill Gates and Warren Buffett speak with journalist Charlie Rose at an event organized by Columbia Business School on January 27, 2017 in New York City. Gates and Buffett spoke on a range of topics including their friendship, business, philanthropy, global health, innovation, and leadership. (Photo by Spencer Platt/Getty Images)

Hot Warren Buffett Stocks To Watch For 2018: Union Pacific Corporation(UNP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    A strange turn of events has sent shares of CSX (CSX)–and other railroads, including Union Pacific (UNP) and Canadian Pacific Railway (CP)–soaring today. It all started when Hunter Harrison announced that he would leave Canadian Pacific ahead of schedule to team up with activist investor for the turnaround of another railway company. That company is thought to be CSX.

Hot Warren Buffett Stocks To Watch For 2018: James River Group Holdings, Ltd.(JRVR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PhiloSmith Capital Corp’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp

    These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 122,700 shares, 7.85% of the total portfolio. Chubb Ltd (CB) – 61,750 shares, 7.59% of the total portfolio. Reinsurance Group of America Inc (RGA) – 65,550 shares, 7.11% of the total portfolio. Brown & Brown Inc (BRO) – 193,225 shares, 7.03% of the total portfolio. Arthur J. Gallagher & Co (AJG) – 143,725 shares, 6.95% of the to

Hot Warren Buffett Stocks To Watch For 2018: Allstate Corporation (The)(ALL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

Hot Warren Buffett Stocks To Watch For 2018: Snap Interactive, Inc. (STVI)

Advisors’ Opinion:

  • [By Vikram Nagarkar]

    According to recent reports, Snap Inc will now look to go public at a valuation of $19 billion to $22 billion, as it goes public under the ticker symbol SNAP on the New York Stock Exchange. Snap Inc’s move to slash its previous seemingly overambitious target of $25 billion comes across as a very good move. Well, there’s no denying the fact that the upcoming Snapchat IPO has generated a lot of investor interest – to the extent that some “overeager” investors even went ahead and bought shares of a similar sounding company,Snap Interactive (OTC:STVI), sending its shares 140% higher. And Snap Interactive’s relatively paltry $50 million market cap may have something to do with it. Be that as it may, Snapchat’s reported initial valuation target of $25 billion was way too ambitious, and there’s no lack of consensus on that front. However, even the scaled down $19 billion target may not be attractive enough.

Hot Warren Buffett Stocks To Watch For 2018: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Best Gold Stocks To Watch For 2018

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Tuesday, February 28.

Bullish Calls

NetApp (NASDAQ:NTAP): It had a good quarter and it can head higher.

Penn National Gaming (NASDAQ:PENN): It’s an inexpensive stock.

Bearish Calls

Southwestern Energy (NYSE:SWN): “You are buying it betting that it’s going to get real hot this summer because the fact is, it did not work this year because it was just too hot in the winter. And that’s why that stock has gone down along with the whole group.”

Occidental Petroleum (NYSE:OXY): Cramer’s trust owns this stock and it’s a poorly run company. Don’t buy.

Transocean (NYSE:RIG): “When Schlumberger (NYSE:SLB) says it’s the bottom, then it’s the bottom, not when Transocean says it.”

Norwegian Cruise Line (NASDAQ:NCLH): No. Carnival Cruise Lines (NYSE:CCL) is a better pick.

Coeur Mining (NYSE:CDE): When it comes to gold, Cramer just likes Randgol d Resources (NASDAQ:GOLD).

Best Gold Stocks To Watch For 2018: Allstate Corporation (The)(ALL)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

Best Gold Stocks To Watch For 2018: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA. Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17. Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents. Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash. TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone. Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA. Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday. Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million. Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday. Sorl Auto
  • [By Lisa Levin]

    Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).

Best Gold Stocks To Watch For 2018: CTI BioPharma Corp.(CTIC)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

Best Gold Stocks To Watch For 2018: Buenaventura Mining Company Inc.(BVN)

Advisors’ Opinion:

  • [By Alex McGuire]

    You see, Money Morning Resource Specialist Peter Krauth expects gold prices to gain 15.4% from their current $1,213 level to $1,400 an ounce this year. This rise will lead to an even bigger rally for gold stocks. Since the beginning of 2017, gold prices are up 5.1%. But the gains in gold stocks like Agnico Eagle Mines Ltd. (NYSE:AEM) and Compania de Minas Buenaventura SAA (NYSE ADR: BVN) have doubled and quadrupled the year-to-date gold price return.